Overview
In May 2026, NASA astronauts aboard the International Space Station (ISS) conducted exciting biomedical experiments. They worked on cancer treatments, cartilage tissue growth, heart stem cells, and DNA-inspired nanomaterials. All this work happened during Expedition 74. The astronauts used the Japanese Kibo laboratory module and its Life Science Glovebox. These space-based studies help us understand diseases and develop new medicines.
Latest News: Biomedical Research on the ISS
NASA astronauts are very busy on the International Space Station. In May 2026, they carried out several biomedical experiments. The focus areas were:
-
Cancer therapeutics (drugs to treat cancer)
-
Cartilage tissue growth (the soft tissue in joints and nose)
-
Heart stem cells (cells that can repair heart damage)
-
DNA-inspired nanomaterials (tiny materials for future medicines)
The work took place during Expedition 74. The astronauts used the Kibo laboratory module, which is Japan’s part of the ISS. They also used a special tool called the Life Science Glovebox. This glovebox allows safe handling of biological samples in microgravity.
Space Cancer Therapeutics in Microgravity
NASA Flight Engineer Chris Williams worked hard in May 2026. He set up Space Cancer Therapeutics hardware inside the Kibo laboratory module. The goal of this experiment was to see how microgravity affects an anti-cancer drug. Scientists wanted to study the drug’s molecular mechanisms in space conditions. The research focused on pancreatic cancer therapies. Pancreatic cancer is very hard to treat on Earth. Space may give new clues about how the drug behaves when gravity is almost zero.
Cartilage Tissue Engineering in Space
Another NASA Flight Engineer, Jessica Meir, studied cartilage tissue growth. She used specialised hardware inside Kibo’s Life Science Glovebox. Cartilage is a connective tissue. We find it in our joints, nose, ear, and rib cage. On Earth, growing three-dimensional cartilage is difficult because gravity pulls cells down. In space, cells can float and form better 3D structures. This helps scientists study how to repair damaged cartilage. The results could help people with joint problems or injuries.
Related Biomedical Experiments on the ISS
Many other experiments happened around the same time.
Heart Stem Cells and Pneumonia Bacteria
On 23 April 2026, Jessica Meir processed heart stem cells. She also worked on pneumonia-causing bacteria. These studies are linked to heart-condition treatments. Scientists want to know how stem cells behave in space. They also want to understand how bacteria change in microgravity. This knowledge can lead to better drugs for heart disease and lung infections.
DNA-Inspired Nanomaterials for Cancer Treatment
On the same date, NASA Flight Engineer Jack Hathaway and ESA astronaut Sophie Adenot worked together. They manufactured DNA-inspired nanomaterials in the Kibo laboratory module. These tiny materials are being studied for cancer and chronic disease treatments. They can be used in immunotherapies (helping the body’s immune system fight cancer) and chemotherapies (drugs that kill cancer cells). Space helps these materials form more uniform and useful structures.
What Is the Kibo Laboratory Module?
Kibo means “hope” in Japanese. It is the Japanese Experiment Module on the ISS. Kibo is a large laboratory that has special facilities for life science experiments. One of its key tools is the Life Science Glovebox. This is a sealed box with built-in gloves. Astronauts put their hands inside to handle cells, bacteria, and other biological samples safely. Kibo also has storage for samples and powerful microscopes.
What Is Microgravity?
Microgravity is the near-weightless condition in space. On the ISS, things float because the station is in free fall around Earth. This condition is very useful for science. For example, cancer cells can form three-dimensional tumour models in microgravity. These include tumour spheroids (small round clumps of cells) and organoids (miniature organs). On Earth, gravity flattens cells. In space, they grow in a more natural 3D shape. This makes drug testing more accurate.
Other Important Space Cancer Research
NASA and the ISS National Laboratory have been doing cancer research for some time.
-
July 2024: The ISS National Laboratory and NASA selected five projects under the “Igniting Innovation” solicitation. One project at the University of California, San Diego, studied accelerated cancer development in microgravity. The team used patient-derived tumour organoids.
-
December 2024: At the Sanford Stem Cell Institute of UC San Diego, tumour spheroids tripled in size in just 10 days in microgravity. This rapid growth helps scientists test drugs faster.
-
June 2025: Cedars-Sinai cell biologists led by Arun Sharma used pluripotent stem cells to create heart organoids in space. They studied how cancer drugs affect the heart. Microgravity helped maintain the 3D structures.
-
Encapsulate also used a “tumour-on-a-chip” system. This tiny device mimics a real tumour. It helps study chemotherapy drugs in space-based cancer models.
A Key Cancer Medicine: Pembrolizumab
Pembrolizumab is a cancer medicine made by Merck. In September 2025, the United States Food and Drug Administration (FDA) approved an injectable form of this drug. It is used for many types of cancer. Space experiments may help improve such drugs further.
Exam-Focused Points
-
Event: Biomedical experiments on ISS during Expedition 74 (May 2026)
-
Astronauts involved: Chris Williams, Jessica Meir, Jack Hathaway (NASA), Sophie Adenot (ESA)
-
Experiments: Cancer therapeutics, cartilage growth, heart stem cells, DNA-inspired nanomaterials
-
Facility used: Japanese Kibo laboratory module and Life Science Glovebox
-
Cancer focus: Pancreatic cancer therapies, drug behaviour in microgravity
-
Cartilage: Connective tissue in joints, nose, ear, rib cage; 3D formation studied in space
-
Heart stem cells: Processed on 23 April 2026 for heart-condition treatments
-
DNA nanomaterials: For immunotherapies and chemotherapies
-
Pembrolizumab: Cancer drug by Merck; FDA approved injectable form in September 2025
-
Microgravity benefits: Tumour spheroids and organoids grow in 3D for better drug testing
-
Key past results: Tumour spheroids tripled in size in 10 days (Dec 2024); heart organoids created in space (June 2025); tumour-on-a-chip for chemotherapy studies
FAQ
Q1: What biomedical experiments did NASA conduct on the ISS in May 2026?
Ans: They studied cancer therapeutics, cartilage tissue growth, heart stem cells, and DNA-inspired nanomaterials.
Q2: Which laboratory module did the astronauts use for these experiments?
Ans: They used the Japanese Kibo laboratory module and its Life Science Glovebox.
Q3: Why is microgravity useful for cancer research?
Ans: Microgravity helps cancer cells form three-dimensional tumour spheroids and organoids, which are better for testing drugs.
Q4: Who is the NASA astronaut that studied cartilage tissue growth in space?
Ans: NASA Flight Engineer Jessica Meir studied cartilage tissue growth in space.
Q5: What is pembrolizumab and when was its injectable form approved?
Ans: Pembrolizumab is a cancer medicine by Merck. Its injectable formulation received US FDA approval in September 2025.